사노피(SNY)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - General 기업입니다. 현재가 $42.48 (-1.53%), 시가총액 $112.08B, PER (주가수익비율) 20.16, 52주 최저~최고 $43.60 ~ $55.44.
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targetin
사노피의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
사노피의 현재 주가는 $42.48 (-1.53%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
사노피의 시가총액은 약 $112.08B입니다. PER은 20.16입니다.
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It als